STOCKHOLM, Sweden, May 9, 2005 (PRIMEZONE) -- Getinge announces that as of today the FDA has lifted the temporary ban imposed in February 2005 on US deliveries from the Gloucester production facility for patient handling equipment. Deliveries from Gloucester to clients in the US will resume with immediate effect.
According to the FDA, measures taken by Extended Care and described in their written reply, were adequate enough to allow a lifting of the embargo without a preceding physical inspection. An audit of the facility will still need to be carried out but no final date has been decided.
The loss of revenue as a consequence of the ban is expected to be below SEK 15 million.
Getinge, 9th May 2005
For further information please contact: Johan Malmquist President and CEO phone +46 (0)35 15 55 00
GETINGE is a leading provider of equipment and systems to customers within health care, extended care and pharmaceutical industries/laboratories. Equipment, services and technologies for infection control, operating theatres, patient hygiene, patient handling and wound care are supplied to customers throughout the world. The Getinge Group has annual sales of SEK 11 billion and 6,800 employees
This information was brought to you by Waymaker http://www.waymaker.net
The following files are available for download: http://wpy.waymaker.net/client/waymaker1/WOLReleaseFile.aspx?id=96485&fn=wkr0001.pdf
-0-